Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain

Agnese Secondo, Giuseppe Pignataro, Paolo Ambrosino, Anna Pannaccione, Pasquale Molinaro, Francesca Boscia, Maria Cantile, Ornella Cuomo, Alba Esposito, Maria Josè Sisalli, Antonella Scorziello, Natascia Guida, Serenella Anzilotti, Ferdinando Fiorino, Beatrice Severino, Vincenzo Santagada, Giuseppe Caliendo, Gianfranco Di Renzo, Lucio Annunziato

Research output: Contribution to journalArticle

Abstract

The Na+/Ca2+ exchanger (NCX), a 10-transmembrane domain protein mainly involved in the regulation of intracellular Ca2+ homeostasis, plays a crucial role in cerebral ischemia. In the present paper, we characterized the effect of the newly synthesized compound 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) on the activity of the three NCX isoforms and on the evolution of cerebral ischemia. BED inhibited NCX isoform 3 (NCX3) activity (IC50 = 1.9 nM) recorded with the help of single-cell microflorimetry, 45Ca2+ radiotracer fluxes, and patch-clamp in whole-cell configuration. Furthermore, this drug displayed negligible effect on NCX2, the other isoform expressed within the CNS, and it failed to modulate the ubiquitously expressed NCX1 isoform. Concerning the molecular site of action, the use of chimera strategy and deletion mutagenesis showed that α1 and α2 repeats of NCX3 represented relevant molecular determinants for BED inhibitory action, whereas the intracellular regulatory f-loop was not involved. At 10 nM, BED worsened the damage induced by oxygen/glucose deprivation (OGD) followed by reoxygenation in cortical neurons through a dysregulation of [Ca2+]i. Furthermore, at the same concentration, BED significantly enhanced cell death in CA3 subregion of hippocampal organotypic slices exposed to OGD and aggravated infarct injury after transient middle cerebral artery occlusion in mice. These results showed that the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride is one of the most potent inhibitor of NCX3 so far identified, representing an useful tool to dissect the role played by NCX3 in the control of Ca2+ homeostasis under physiological and pathological conditions.

Original languageEnglish
Pages (from-to)1361-1370
Number of pages10
JournalACS Chemical Neuroscience
Volume6
Issue number8
DOIs
Publication statusPublished - Aug 19 2015

Fingerprint

Neurons
Brain
Protein Isoforms
Pharmacology
Wounds and Injuries
Brain Ischemia
Homeostasis
Oxygen
Glucose
Mutagenesis
Middle Cerebral Artery Infarction
Clamping devices
Cell death
benzamide
5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride
Inhibitory Concentration 50
Cell Death
Fluxes
Pharmaceutical Preparations
Proteins

Keywords

  • cerebral ischemia
  • NCX isoforms
  • NCX3 inhibitor
  • OGD
  • Sodium calcium exchanger

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Physiology
  • Cognitive Neuroscience

Cite this

Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain. / Secondo, Agnese; Pignataro, Giuseppe; Ambrosino, Paolo; Pannaccione, Anna; Molinaro, Pasquale; Boscia, Francesca; Cantile, Maria; Cuomo, Ornella; Esposito, Alba; Sisalli, Maria Josè; Scorziello, Antonella; Guida, Natascia; Anzilotti, Serenella; Fiorino, Ferdinando; Severino, Beatrice; Santagada, Vincenzo; Caliendo, Giuseppe; Di Renzo, Gianfranco; Annunziato, Lucio.

In: ACS Chemical Neuroscience, Vol. 6, No. 8, 19.08.2015, p. 1361-1370.

Research output: Contribution to journalArticle

Secondo, A, Pignataro, G, Ambrosino, P, Pannaccione, A, Molinaro, P, Boscia, F, Cantile, M, Cuomo, O, Esposito, A, Sisalli, MJ, Scorziello, A, Guida, N, Anzilotti, S, Fiorino, F, Severino, B, Santagada, V, Caliendo, G, Di Renzo, G & Annunziato, L 2015, 'Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain', ACS Chemical Neuroscience, vol. 6, no. 8, pp. 1361-1370. https://doi.org/10.1021/acschemneuro.5b00043
Secondo, Agnese ; Pignataro, Giuseppe ; Ambrosino, Paolo ; Pannaccione, Anna ; Molinaro, Pasquale ; Boscia, Francesca ; Cantile, Maria ; Cuomo, Ornella ; Esposito, Alba ; Sisalli, Maria Josè ; Scorziello, Antonella ; Guida, Natascia ; Anzilotti, Serenella ; Fiorino, Ferdinando ; Severino, Beatrice ; Santagada, Vincenzo ; Caliendo, Giuseppe ; Di Renzo, Gianfranco ; Annunziato, Lucio. / Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain. In: ACS Chemical Neuroscience. 2015 ; Vol. 6, No. 8. pp. 1361-1370.
@article{40e9c97798334857a4b4a8aa0aa0dcf1,
title = "Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain",
abstract = "The Na+/Ca2+ exchanger (NCX), a 10-transmembrane domain protein mainly involved in the regulation of intracellular Ca2+ homeostasis, plays a crucial role in cerebral ischemia. In the present paper, we characterized the effect of the newly synthesized compound 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) on the activity of the three NCX isoforms and on the evolution of cerebral ischemia. BED inhibited NCX isoform 3 (NCX3) activity (IC50 = 1.9 nM) recorded with the help of single-cell microflorimetry, 45Ca2+ radiotracer fluxes, and patch-clamp in whole-cell configuration. Furthermore, this drug displayed negligible effect on NCX2, the other isoform expressed within the CNS, and it failed to modulate the ubiquitously expressed NCX1 isoform. Concerning the molecular site of action, the use of chimera strategy and deletion mutagenesis showed that α1 and α2 repeats of NCX3 represented relevant molecular determinants for BED inhibitory action, whereas the intracellular regulatory f-loop was not involved. At 10 nM, BED worsened the damage induced by oxygen/glucose deprivation (OGD) followed by reoxygenation in cortical neurons through a dysregulation of [Ca2+]i. Furthermore, at the same concentration, BED significantly enhanced cell death in CA3 subregion of hippocampal organotypic slices exposed to OGD and aggravated infarct injury after transient middle cerebral artery occlusion in mice. These results showed that the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride is one of the most potent inhibitor of NCX3 so far identified, representing an useful tool to dissect the role played by NCX3 in the control of Ca2+ homeostasis under physiological and pathological conditions.",
keywords = "cerebral ischemia, NCX isoforms, NCX3 inhibitor, OGD, Sodium calcium exchanger",
author = "Agnese Secondo and Giuseppe Pignataro and Paolo Ambrosino and Anna Pannaccione and Pasquale Molinaro and Francesca Boscia and Maria Cantile and Ornella Cuomo and Alba Esposito and Sisalli, {Maria Jos{\`e}} and Antonella Scorziello and Natascia Guida and Serenella Anzilotti and Ferdinando Fiorino and Beatrice Severino and Vincenzo Santagada and Giuseppe Caliendo and {Di Renzo}, Gianfranco and Lucio Annunziato",
year = "2015",
month = "8",
day = "19",
doi = "10.1021/acschemneuro.5b00043",
language = "English",
volume = "6",
pages = "1361--1370",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Pharmacological Characterization of the Newly Synthesized 5-Amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide Hydrochloride (BED) as a Potent NCX3 Inhibitor That Worsens Anoxic Injury in Cortical Neurons, Organotypic Hippocampal Cultures, and Ischemic Brain

AU - Secondo, Agnese

AU - Pignataro, Giuseppe

AU - Ambrosino, Paolo

AU - Pannaccione, Anna

AU - Molinaro, Pasquale

AU - Boscia, Francesca

AU - Cantile, Maria

AU - Cuomo, Ornella

AU - Esposito, Alba

AU - Sisalli, Maria Josè

AU - Scorziello, Antonella

AU - Guida, Natascia

AU - Anzilotti, Serenella

AU - Fiorino, Ferdinando

AU - Severino, Beatrice

AU - Santagada, Vincenzo

AU - Caliendo, Giuseppe

AU - Di Renzo, Gianfranco

AU - Annunziato, Lucio

PY - 2015/8/19

Y1 - 2015/8/19

N2 - The Na+/Ca2+ exchanger (NCX), a 10-transmembrane domain protein mainly involved in the regulation of intracellular Ca2+ homeostasis, plays a crucial role in cerebral ischemia. In the present paper, we characterized the effect of the newly synthesized compound 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) on the activity of the three NCX isoforms and on the evolution of cerebral ischemia. BED inhibited NCX isoform 3 (NCX3) activity (IC50 = 1.9 nM) recorded with the help of single-cell microflorimetry, 45Ca2+ radiotracer fluxes, and patch-clamp in whole-cell configuration. Furthermore, this drug displayed negligible effect on NCX2, the other isoform expressed within the CNS, and it failed to modulate the ubiquitously expressed NCX1 isoform. Concerning the molecular site of action, the use of chimera strategy and deletion mutagenesis showed that α1 and α2 repeats of NCX3 represented relevant molecular determinants for BED inhibitory action, whereas the intracellular regulatory f-loop was not involved. At 10 nM, BED worsened the damage induced by oxygen/glucose deprivation (OGD) followed by reoxygenation in cortical neurons through a dysregulation of [Ca2+]i. Furthermore, at the same concentration, BED significantly enhanced cell death in CA3 subregion of hippocampal organotypic slices exposed to OGD and aggravated infarct injury after transient middle cerebral artery occlusion in mice. These results showed that the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride is one of the most potent inhibitor of NCX3 so far identified, representing an useful tool to dissect the role played by NCX3 in the control of Ca2+ homeostasis under physiological and pathological conditions.

AB - The Na+/Ca2+ exchanger (NCX), a 10-transmembrane domain protein mainly involved in the regulation of intracellular Ca2+ homeostasis, plays a crucial role in cerebral ischemia. In the present paper, we characterized the effect of the newly synthesized compound 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) on the activity of the three NCX isoforms and on the evolution of cerebral ischemia. BED inhibited NCX isoform 3 (NCX3) activity (IC50 = 1.9 nM) recorded with the help of single-cell microflorimetry, 45Ca2+ radiotracer fluxes, and patch-clamp in whole-cell configuration. Furthermore, this drug displayed negligible effect on NCX2, the other isoform expressed within the CNS, and it failed to modulate the ubiquitously expressed NCX1 isoform. Concerning the molecular site of action, the use of chimera strategy and deletion mutagenesis showed that α1 and α2 repeats of NCX3 represented relevant molecular determinants for BED inhibitory action, whereas the intracellular regulatory f-loop was not involved. At 10 nM, BED worsened the damage induced by oxygen/glucose deprivation (OGD) followed by reoxygenation in cortical neurons through a dysregulation of [Ca2+]i. Furthermore, at the same concentration, BED significantly enhanced cell death in CA3 subregion of hippocampal organotypic slices exposed to OGD and aggravated infarct injury after transient middle cerebral artery occlusion in mice. These results showed that the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride is one of the most potent inhibitor of NCX3 so far identified, representing an useful tool to dissect the role played by NCX3 in the control of Ca2+ homeostasis under physiological and pathological conditions.

KW - cerebral ischemia

KW - NCX isoforms

KW - NCX3 inhibitor

KW - OGD

KW - Sodium calcium exchanger

UR - http://www.scopus.com/inward/record.url?scp=84939787642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939787642&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.5b00043

DO - 10.1021/acschemneuro.5b00043

M3 - Article

C2 - 25942323

AN - SCOPUS:84939787642

VL - 6

SP - 1361

EP - 1370

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 8

ER -